BIOMAT Database Logo BIOMAT Database Logo

Factors that influence the antagonistic properties of angiotensin II antagonists. 1973

M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002854 Chromatography, Paper An analytical technique for resolution of a chemical mixture into its component compounds. Compounds are separated on an adsorbent paper (stationary phase) by their varied degree of solubility/mobility in the eluting solvent (mobile phase). Paper Chromatography,Chromatographies, Paper,Paper Chromatographies
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D004590 Electrophoresis, Paper Electrophoresis in which paper is used as the diffusion medium. This technique is confined almost entirely to separations of small molecules such as amino acids, peptides, and nucleotides, and relatively high voltages are nearly always used. Paper Electrophoresis
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas

Related Publications

M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus
Pharmacological properties of angiotensin II receptor antagonists.
November 1999, The Canadian journal of cardiology,
M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus
[Angiotensin II antagonists].
January 1995, Duodecim; laaketieteellinen aikakauskirja,
M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus
Angiotensin II antagonists.
November 1993, Clinical and experimental hypertension (New York, N.Y. : 1993),
M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus
Pharmacological properties of angiotensin II antagonists: examining all the therapeutic implications.
September 2001, Journal of the renin-angiotensin-aldosterone system : JRAAS,
M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus
Hemodynamic effects of angiotensin II and the influence of angiotensin receptor antagonists in pithed rabbits.
May 1995, Journal of cardiovascular pharmacology,
M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus
Angiotensin II receptors and angiotensin II receptor antagonists.
June 1993, Pharmacological reviews,
M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus
[Nonpeptide angiotensin II antagonists].
April 1992, Nihon rinsho. Japanese journal of clinical medicine,
M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus
[Angiotensin II receptor antagonists].
June 1995, Medizinische Monatsschrift fur Pharmazeuten,
M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus
[Angiotensin II receptor antagonists].
April 2000, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
M C Khosla, and M M Hall, and R R Smeby, and F M Bumpus
Angiotensin II receptor antagonists.
February 2000, Lancet (London, England),
Copied contents to your clipboard!